William Rigby

5PUBLICATIONS
10CO-AUTHORS
AutoimmunityInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Toxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 27, 2026
Costimulatory blockade depletes T peripheral helper, late-activated naïve, and DN2 B cells in rheumatoid arthritis.

Jasmine J Shwetar, Abhimanyu Amarnani, William Rigby

|Jul 17, 2021
Differential Enhancement of Neutrophil Phagocytosis by Anti-Bactericidal/Permeability-Increasing Protein Antibodies.

Jomkuan Theprungsirikul, Sladjana Skopelja-Gardner, Rachel M Wierzbicki

|Feb 02, 2021
Upadacitinib in Rheumatoid Arthritis: A Benefit-Risk Assessment Across a Phase III Program.

Philip G Conaghan, Eduardo Mysler, Yoshiya Tanaka

|Dec 12, 2017
Review of Routine Laboratory Monitoring for Patients with Rheumatoid Arthritis Receiving Biologic or Nonbiologic DMARDs.

William F C Rigby, Kathy Lampl, Jason M Low

Pageof 1